| Ethan L Ferguson, MD | |
|
1801 N Senate Blvd Ste 220, Indianapolis, IN 46202-1260 | |
| (317) 688-5500 | |
| (317) 688-5505 |
| Full Name | Ethan L Ferguson |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 8 Years |
| Location | 1801 N Senate Blvd Ste 220, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043666191 | NPI | - | NPPES |
| 064740077 | Other | IN | MEDICARE PTAN |
| 300078672 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 01090971A (Indiana) | Secondary |
| 208800000X | Urology | 35.142317 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Eskenazi Health | Indianapolis, IN | Hospital |
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Union Hospital Inc | Terre haute, IN | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Urologists Inc Pc | 4284604208 | 29 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.
When Wal-Mart endorsed President Obama's health care plan in 2009, CEO Mike Duke said it did so "to remove the burden that is crushing America's businesses and hampering our competitiveness in the global economy." That doesn't seem to be working out too well -; for all Americans, and especially for Wal-Mart's employees.
Supplements of vitamin D and omega-3 fatty acids (often sold as fish oil) do not help people with type 2 diabetes stave off chronic kidney disease, according to findings from the largest clinical study to date of the supplements in this patient population.
When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment. Now, results of a new survey by the American Academy of Dermatology (Academy) confirmed that the majority of people still idolize the bronzed look of a tan despite wanting to protect themselves from skin cancer.
› Verified 9 days ago
| Entity Name | University Urologists Inc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104877141 PECOS PAC ID: 4284604208 Enrollment ID: O20040728000391 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.
When Wal-Mart endorsed President Obama's health care plan in 2009, CEO Mike Duke said it did so "to remove the burden that is crushing America's businesses and hampering our competitiveness in the global economy." That doesn't seem to be working out too well -; for all Americans, and especially for Wal-Mart's employees.
Supplements of vitamin D and omega-3 fatty acids (often sold as fish oil) do not help people with type 2 diabetes stave off chronic kidney disease, according to findings from the largest clinical study to date of the supplements in this patient population.
When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment. Now, results of a new survey by the American Academy of Dermatology (Academy) confirmed that the majority of people still idolize the bronzed look of a tan despite wanting to protect themselves from skin cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ethan L Ferguson, MD 1801 N Senate Blvd Ste 220, Indianapolis, IN 46202-1260 Ph: (317) 962-3700 | Ethan L Ferguson, MD 1801 N Senate Blvd Ste 220, Indianapolis, IN 46202-1260 Ph: (317) 688-5500 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.
When Wal-Mart endorsed President Obama's health care plan in 2009, CEO Mike Duke said it did so "to remove the burden that is crushing America's businesses and hampering our competitiveness in the global economy." That doesn't seem to be working out too well -; for all Americans, and especially for Wal-Mart's employees.
Supplements of vitamin D and omega-3 fatty acids (often sold as fish oil) do not help people with type 2 diabetes stave off chronic kidney disease, according to findings from the largest clinical study to date of the supplements in this patient population.
When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment. Now, results of a new survey by the American Academy of Dermatology (Academy) confirmed that the majority of people still idolize the bronzed look of a tan despite wanting to protect themselves from skin cancer.
› Verified 9 days ago
Hristos Kaimakliotis, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1701 N Senate Ave, Indianapolis, IN 46202 Phone: 317-948-6351 | |
Dr. Charles Randall Powell Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Barnhill Dr., Indianapolis, IN 46202 Phone: 317-274-4622 Fax: 317-274-0174 | |
Dr. Thomas Maxwell Shelton, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Barnhill Dr # 150, Indianapolis, IN 46202 Phone: 317-278-0221 | |
Kelly Clint Cary, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 535 Barnhill Dr, Ste 420, Indianapolis, IN 46202 Phone: 317-278-1979 Fax: 317-278-1981 | |
Jacob D Mcfadden, M.D. Urology Medicare: Medicare Enrolled Practice Location: 535 Barnhill Dr Ste 150, Indianapolis, IN 46202 Phone: 317-278-0221 | |
Alexander J Tatem, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 8240 Naab Rd Ste 220, Indianapolis, IN 46260 Phone: 317-890-2000 |